ProShare Advisors’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-478
Closed -$12.6K – 1960
2026
Q1
$12.6K Sell
478
-89
-16% -$11.2K ﹤0.01% 1852
2025
Q4
$141K Buy
567
+161
+40% +$36.8K ﹤0.01% 1810
2025
Q3
$85.4K Sell
406
-81
-17% -$14.3K ﹤0.01% 1864
2025
Q2
$47.9K Buy
+487
New +$42.5K ﹤0.01% 1997
2023
Q4
– Sell
-184
Closed -$12.3K – 1960
2023
Q3
$12.3K Buy
+184
New +$17K ﹤0.01% 1801
2023
Q2
– Sell
-175
Closed -$17.6K – 1870
2023
Q1
$17.6K Sell
175
-24
-12% -$3.67K ﹤0.01% 1741
2022
Q4
$34.5K Buy
199
+13
+7% +$8.56K ﹤0.01% 1770
2022
Q3
$178K Buy
186
+22
+13% +$21.8K ﹤0.01% 1433
2022
Q2
$110K Sell
164
-81
-33% -$50.2K ﹤0.01% 1596
2022
Q1
$170K Sell
245
-59
-19% -$45.5K ﹤0.01% 1922
2021
Q4
$276K Buy
304
+2
+0.7% +$1.9K ﹤0.01% 1838
2021
Q3
$304K Sell
302
-70
-19% -$51.6K ﹤0.01% 1541
2021
Q2
$242K Buy
372
+52
+16% +$36.1K ﹤0.01% 2028
2021
Q1
$237K Buy
320
+17
+6% +$13.7K ﹤0.01% 1936
2020
Q4
$235K Buy
303
+63
+26% +$49.6K ﹤0.01% 1763
2020
Q3
$238K Buy
240
+4
+2% +$4.24K ﹤0.01% 1324
2020
Q2
$245K Buy
236
+91
+63% +$91.6K ﹤0.01% 1346
2020
Q1
$118K Sell
145
-106
-42% -$111K ﹤0.01% 1062
2019
Q4
$314K Buy
+251
New +$404K ﹤0.01% 1316

Other funds holding GOSS

ProShare Advisors's GOSS Position: Q2 2026 in Review

ProShare Advisors sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 478 shares — an estimated $12.6K sold.

ProShare Advisors first reported a position in GOSS in Q4 2019 and held it in 19 quarters. The position peaked at $314K in Q4 2019. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • ProShare Advisors reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • ProShare Advisors sold 478 Gossamer Bio shares in Q2 2026, an estimated $12.6K.
  • ProShare Advisors first reported a position in Gossamer Bio in Q4 2019 and held it in 19 quarters.
  • ProShare Advisors's Gossamer Bio position peaked at $314K in Q4 2019.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.